Table 2 Comfort with prescribing psychotropic medications
Variable | Pre-training (T1) | 3-day training completion (T2) | 6-month training completion (T3) |
|---|---|---|---|
Stimulants | 124 | 107 | 80 |
Yes | 105 (84.7%) | 100 (93.5%) | 76 (95.0%) |
No | 19 (15.3%) | 7 (6.5%) | 4 (5.0%) |
p-value | 0.01 (T1 vs. T2) | 0.63 (T2 vs. T3) | 0.01 (T1 vs. T3) |
Atypical antipsychotics | 124 | 107 | 80 |
Yes | 62 (50.0%) | 87 (81.3%) | 68 (85.0%) |
No | 62 (50.0%) | 20 (18.7%) | 12 (15.0%) |
p-value | < 0.001 (T1 vs. T2) | 0.27 (T2 vs. T3) | < 0.001 (T1 vs. T3) |
Selective Serotonin Reuptake Inhibitors (SSRI) | 124 | 107 | 81 |
Yes | 115 (92.7%) | 105 (98.1%) | 78 (97.5%) |
No | 9 (7.3%) | 2 (1.9%) | 2 (2.5%) |
p-value | 0.04 (T1 vs. T2) | 1.00 (T2 vs. T3) | 0.29 (T1 vs. T3) |
Mood stabilizers | 124 | 107 | 81 |
Yes | 22 (17.7%) | 32 (29.9%) | 19 (23.8%) |
No | 102 (82.3%) | 75 (70.1%) | 61 (76.2%) |
p-value | < 0.001 (T1 vs. T2) | 0.82 (T2 vs. T3) | 0.02 (T1 vs. T3) |